GeoVax Labs, Inc. New (GOVX) is a publicly traded Healthcare sector company. As of July 11, 2026, GOVX trades at $1.16 with a market cap of $6.10M and a P/E ratio of -0.05. GOVX moved +1.28% today. Year to date, GOVX is -72.40%; over the trailing twelve months it is -92.92%. Its 52-week range spans $0.96 to $78.75. Analyst consensus is buy with an average price target of $10.00. Rallies surfaces GOVX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for GOVX, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $1.16 |
| Market Cap | $6.10M |
| P/E Ratio | -0.05 |
| EPS | $-24.71 |
| Dividend Yield | 0.00% |
| 52-Week High | $78.75 |
| 52-Week Low | $0.96 |
| Volume | 78.56K |
| Avg Volume | 0 |
| Revenue (TTM) | $852.28K |
| Net Income | $-21.37M |
| Gross Margin | 0.00% |
2 analysts cover GOVX: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.00.